info@strategicmarketresearch.com
92, An Guha Lane, Arya Samaj Gali, Sambalpur, Odisha -768001
Indian Flag  IN: +91-826-083-6500
Home » pharmaceuticals

pharmaceuticals

Bronchodilators Market By Drug Class (Beta-2 Adrenergic Agonists, Anticholinergics, Theophylline, Combination Therapies); By Route of Administration (Inhalation, Oral, Injectable); By Indication (Asthma, Chronic Obstructive Pulmonary Disease, Others); By End User (Hospitals, Retail Pharmacies, Homecare Settings, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Bronchodilators Market will witness a robust CAGR of 6.7 % , valued at $17.9 billion in 2024 , expected to appreciate and reach $ 26.58 billion by 20... Read More

Published Date: OCT-2025 | No Of Pages:151 | $ 4485

Sustained Release Excipients Market By Product Type (Polymers [Natural, Synthetic], Coatings [Functional, Osmotic], Minerals, Gums & Lipids); By Formulation Type (Oral Tablets, Capsules, Injectables, Implants); By Route of Administration (Oral, Parenteral, Transdermal, Others); By End User (Pharmaceutical Companies, CMOs, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Sustained Release Excipients Market will witness a robust CAGR of 7.1% , valued at $2.97 billion in 2024 , and is expected to appreciate and reach $4.79 billion by 2030 , co... Read More

Published Date: OCT-2025 | No Of Pages:175 | $ 4485

OTC Dry Eye Drops Market By Product Type (Artificial Tears, Lubricant Eye Drops, Gel Drops, Specialty Formulations); By Formulation (Preservative-Free, With Preservatives); By Distribution Channel (Retail Pharmacies & Drug Stores, Online Pharmacies & E-commerce, Supermarkets/Hypermarkets); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global OTC Dry Eye Drops Market will witness a robust CAGR of 6.8% , valued at USD 3.42 billion in 2024 , expected to appreciate and reach USD 5.07 billion by 2030 , ... Read More

Published Date: OCT-2025 | No Of Pages:173 | $ 4485

Muscle Relaxant Drugs Market By Drug Class (Centrally Acting Skeletal Muscle Relaxants, Direct-Acting Muscle Relaxants); By Route of Administration (Oral, Injectable); By Application (Musculoskeletal Conditions, Neurological Disorders, Perioperative and ICU Care); By End User (Hospitals, Outpatient Clinics, Rehabilitation Centers, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Muscle Relaxant Drugs Market will witness a robust CAGR of 5.8% , valued at $2.34 billion in 2024, expected to appreciate and reach $3.29 billion by 2030, confirms Strategic... Read More

Published Date: OCT-2025 | No Of Pages:155 | $ 4485

Alpha Emitter Market By Isotope Type (Actinium-225, Radium-223, Astatine-211, Lead-212, Others); By Application (Prostate Cancer, Bone Metastases, Leukemia & Lymphoma, Neuroendocrine Tumors, Others); By End User (Hospitals & Oncology Clinics, Radiopharmacies, Academic Institutions, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Alpha Emitter Market will witness a strong CAGR of 13.7% , valued at $990 million in 2024 , and is projected to grow significantly to reach around $2.15 billion by 2030 , co... Read More

Published Date: OCT-2025 | No Of Pages:155 | $ 4485

Erythropoietin Drugs Market By Drug Class (Epoetin Alfa, Darbepoetin Alfa, Epoetin Beta, Others); By Application (Chronic Kidney Disease, Cancer, HIV, Surgical Procedures, Others); By Route of Administration (Intravenous, Subcutaneous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Erythropoietin Drugs Market will witness a robust CAGR of 8.2% , valued at $ 11.9 billion in 2024 , expected to appreciate and reach $ 18.9 billion b... Read More

Published Date: OCT-2025 | No Of Pages:155 | $ 4485

Inhalable Drugs Market by Product Type (MDIs, DPIs, Nebulizers); By Application (Asthma, COPD, Other Respiratory Disorders); By End-User (Hospitals, Clinics, Home Care); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Inhalable Drugs Market will witness a robust CAGR of 6.3% , valued at $20.5 billion in 2024 , expected to appreciate and reach $30.5 billion by 2030 , c... Read More

Published Date: OCT-2025 | No Of Pages:173 | $ 4485

Corticosteroids Market By Product Type (Systemic Corticosteroids, Topical Corticosteroids, Inhaled Corticosteroids, Ophthalmic Corticosteroids, Intranasal Corticosteroids); By Route of Administration (Oral, Parenteral, Topical, Inhaled, Ophthalmic, Intranasal); By Application (Respiratory Diseases, Dermatological Disorders, Autoimmune & Inflammatory Disorders, Ophthalmic Conditions, Endocrine Disorders, Other Indications); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Corticosteroids Market will witness a robust CAGR of 6.74 % , valued at $16.2 billion in 2024, expected to appreciate and reach $21.4 billion by 2030, confirms Strate... Read More

Published Date: OCT-2025 | No Of Pages:154 | $ 4485

PARP Inhibitor Market By Drug Type (Olaparib, Niraparib, Rucaparib, Talazoparib, Others); By Indication (Ovarian Cancer, Breast Cancer, Prostate Cancer, Pancreatic Cancer, Other Solid Tumors); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global PARP Inhibitor Market will witness a sustained CAGR of 12.6% , valued at $5.1 billion in 2024 , and is expected to appreciate and reach $11.7 billion by 2030 ,... Read More

Published Date: OCT-2025 | No Of Pages:155 | $ 4485

Antihypertensive Drugs Market By Product Type (ACE Inhibitors, Calcium Channel Blockers, Diuretics, Beta-blockers, ARBs); By Therapeutic Class (Monotherapy, Combination Therapy); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Antihypertensive Drugs Market will experience a steady growth trajectory from 2024 to 2030, driven by the increasing prevalence of hypertension globally, especially among aging populations. The global ... Read More

Published Date: OCT-2025 | No Of Pages:151 | $ 4485

Microneedle Flu Vaccine Market By Product Type (Solid, Dissolving, Coated, Hollow); By Route of Administration (Transdermal, Intradermal); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online, Vaccination Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Microneedle Flu Vaccine Market will witness a robust CAGR of 18.4% , valued at $516 million in 2024 , expected to appreciate and reach $1.43 billion by 2030Read More

Published Date: OCT-2025 | No Of Pages:152 | $ 4485

Diphenhydramine Market By Product Type (Branded, Generic); By Route of Administration (Oral, Topical, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Diphenhydramine Market is projected to expand steadily between 2024 and 2030, growing at a Cagr Of 5.8% . Valued at around USD 350 Million In 2024... Read More

Published Date: OCT-2025 | No Of Pages:156 | $ 4485

Angina Pectoris Drugs Market By Drug Class (Nitrates, Beta-Blockers, Calcium Channel Blockers, Antiplatelet Agents, Ranolazine and Novel Anti-Anginals); By Route of Administration (Oral, Intravenous, Transdermal); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Angina Pectoris Drugs Market will witness a robust CAGR of 5.7% , valued at $9.2 billion in 2024 , expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:172 | $ 4485

Myelodysplastic Syndrome Drugs Market By Drug Class (Hypomethylating Agents, Immunomodulatory Drugs, Targeted Therapies, Supportive Care Drugs); By Route of Administration (Oral, Injectable); By End User (Hospitals, Oncology Clinics, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Myelodysplastic Syndrome (MDS) Drugs Market will witness a robust CAGR of 10.1% , valued at USD 2.1 billion in 2... Read More

Published Date: OCT-2025 | No Of Pages:179 | $ 4485

Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Methicillin-Resistant Staphylococcus Aureus Drugs Market By Drug Class (Glycopeptides, Oxazolidinones, Lipopeptides, Cephalosporins, Tetracyclines, Others); By Route of Administration (Oral, Parenteral, Topical); By Indication (Skin and Soft Tissue Infections, Bloodstream Infections, Pneumonia, Bone and Joint Infections, Others); By End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Institutions, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market will witness a promising CAGR of 6.4 % ... Read More

Published Date: OCT-2025 | No Of Pages:188 | $ 4485

Immune Checkpoint Inhibitors Market By Drug Type (PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors, Others); By Cancer Type (Lung, Melanoma, Bladder, Breast, Liver, Others); By End User (Hospitals & Cancer Centers, Academic Institutes, Clinics, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Immune Checkpoint Inhibitors Market will witness a robust CAGR of 13.8% , valued at $42.3 billion in 2024 , and is expected to appreciate and reach $102.1 billion ... Read More

Published Date: OCT-2025 | No Of Pages:185 | $ 4485

Empty Capsules Market By Capsule Type (Gelatin, Vegetarian, Others); By End-User Application (Pharmaceutical, Nutraceutical, Cosmetic); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Empty Capsules Market will witness a robust CAGR of 5.6% , valued at USD 5.6 billion in 2024 , expected to appreciate and reach U... Read More

Published Date: OCT-2025 | No Of Pages:182 | $ 4485

Plasma Protease C1-Inhibitor Market By Product Type (Plasma-Derived C1-Inhibitor, Recombinant C1-Inhibitor); By Route of Administration (Intravenous, Subcutaneous); By Indication (Hereditary Angioedema, Acquired Angioedema, Other Complement Disorders); By End User (Hospitals, Specialty Clinics, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Plasma Protease C1 -Inhibitor Market will witness a robust CAGR of 7.4% , valued at USD 1.14 billion in 2024 , and is expected to appreci... Read More

Published Date: OCT-2025 | No Of Pages:159 | $ 4485

HPV Associated Disorders Market By Product Type (Prophylactic Vaccines, Therapeutic Vaccines, Diagnostic Assays, Topical and Systemic Treatments); By Indication (Cervical Cancer, Genital Warts, Oropharyngeal Cancers, Recurrent Respiratory Papillomatosis); By End User (Hospitals & Specialty Clinics, Diagnostic Laboratories, Public Health Agencies & NGOs, Academic Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global HPV Associated Disorders Market will witness a robust CAGR of 7.2% , valued at USD 4.8 billion in 2024 , expected to appreciate and reach USD 7.8 ... Read More

Published Date: OCT-2025 | No Of Pages:200 | $ 4485

Postpartum Depression Drugs Market By Drug Class (Selective Serotonin Reuptake Inhibitors, Neuroactive Steroids, Tricyclic Antidepressants, Atypical Antidepressants, Others); By Route of Administration (Oral, Intravenous, Transdermal, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Postpartum Depression (PPD) Drugs Market will witness a robust CAGR of 28.6% , valued at $1.72 billion in 2024 , and is expected to appre... Read More

Published Date: OCT-2025 | No Of Pages:192 | $ 4485

Anticoagulant Reversal Drugs Market By Drug Type (Vitamin K Antagonist Reversal Agents, Heparin and LMWH Reversal Agents, Direct Oral Anticoagulant Reversal Agents); By Route of Administration (Intravenous, Oral); By End User (Hospitals and Trauma Centers, Ambulatory Surgical Centers, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The global anticoagulant reversal drugs market will witness a robust CAGR of 9.2% , valued at $1.24 billion in 2024 , expected to appreciate and reach $2.32 billion by 2030Read More

Published Date: OCT-2025 | No Of Pages:152 | $ 4485

Hyperlipidemia Drugs Market By Drug Class (Statins, PCSK9 Inhibitors, Bile Acid Sequestrants, Cholesterol Absorption Inhibitors, Fibrates, Niacin, Others); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Hyperlipidemia Drugs Market will witness a robust CAGR of 6.5% , valued at USD 16.8 billion in 2024, and is expected to appreciate and re... Read More

Published Date: OCT-2025 | No Of Pages:177 | $ 4485

Superdisintegrants Market By Product Type (Synthetic, Natural, Co-Processed); By Formulation Type (Tablets, Capsules, Orodispersible Tablets, Others); By Therapeutic Area (Cardiovascular, Neurological, Gastrointestinal, Infectious Diseases, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Superdisintegrants Market will witness a robust CAGR of 6.94 % , valued at approximately USD 460 million in 2024 , and i... Read More

Published Date: OCT-2025 | No Of Pages:174 | $ 4485

Conjugate Vaccine Market By Type (Monovalent, Multivalent); By Disease Indication (Pneumococcal, Meningococcal, Hib, Typhoid, Others); By Age Group (Pediatrics, Adults, Geriatrics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Conjugate Vaccine Market will witness a robust CAGR of 8.3 % , valued at $14.1 billion in 2024 , expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:200 | $ 4485

Kidney Cancer Drugs Market By Therapeutic Class (Targeted Therapy, Immunotherapy, Combination Therapy, Others); By Disease Stage (Localized RCC, Advanced/Metastatic RCC); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Kidney Cancer Drugs Market will witness a robust CAGR of 8.7% , valued at approximately $ 4.54 billion in 2024 , expected to appreciate a... Read More

Published Date: OCT-2025 | No Of Pages:191 | $ 4485

Immunomodulators Market By Drug Class (Immunosuppressants, Immunostimulants, Monoclonal Antibodies, Interferons, Interleukins); By Route of Administration (Oral, Injectable, Intravenous); By Indication (Autoimmune Diseases, Organ Transplantation, Oncology, Infectious Diseases, Others); By End User (Hospitals, Specialty Clinics, Research Institutes, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Immunomodulators Market will witness a robust CAGR of 8.2% , valued at USD 84.2 billion in 2024, expected to appreciate and reach USD 134.7 billion by 203... Read More

Published Date: OCT-2025 | No Of Pages:170 | $ 4485

Interleukin Inhibitors Market By Type (IL-1, IL-6, IL-17, IL-23, IL-12/23, IL-4/13, Others); By Indication (Rheumatoid Arthritis, Psoriasis, Inflammatory Bowel Disease, Asthma, Atopic Dermatitis, Others); By Route of Administration (Subcutaneous, Intravenous, Oral); By End User (Hospitals, Specialty Clinics, Homecare, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Interleukin Inhibitors Market will witness a robust CAGR of 10.2% , valued at $22.8 billion in 2024 , expected to appreciate and reach $45.4 billion by 2030Read More

Published Date: OCT-2025 | No Of Pages:190 | $ 4485

Congestive Heart Failure (CHF) Drugs Market Congestive Heart Failure Drugs Market By Drug Class (ACE Inhibitors, Beta-Blockers, Diuretics, ARNIs, SGLT2 Inhibitors, Others); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Congestive Heart Failure ( CHF ) Drugs Market will witness a steady CAGR of 5.8% , valued at approximately $14.2 billion in 2024<... Read More

Published Date: OCT-2025 | No Of Pages:160 | $ 4485

Paracetamol Intravenous (IV) Market By Formulation Type (Standard Vial Injection, Ready-to-Use Infusion Bag, Ampoule-Based Formulations); By Application (Postoperative Pain Management, Fever Reduction in Critical Care, Trauma and Emergency Care); By End User (Hospitals, Ambulatory Surgical Centers, Emergency Departments and ICUs, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Paracetamol Intravenous ( IV ) Market will witness a robust CAGR of 5.8% , valued at approximately $785 million in 2024 , and is expected... Read More

Published Date: OCT-2025 | No Of Pages:175 | $ 4485

Digestive and Intestinal Remedies Market By Product Type (Antacids, Laxatives, Anti-diarrheal Agents, Probiotics and Prebiotics, Digestive Enzymes, IBS/IBD-Specific Therapies, Herbal and Natural Remedies); By Disease Indication (Constipation, Diarrhea, GERD, IBS, IBD, Lactose Intolerance, Gut Health Maintenance); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies, Supermarkets, Health & Wellness Stores); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Digestive And Intestinal Remedies market will witness a robust CAGR of 6.4% , valued at $42.7 billion in 2024 , expected to apprecia... Read More

Published Date: OCT-2025 | No Of Pages:164 | $ 4485

Non-Opioid Pain Patches Market By Product Type (Lidocaine, Capsaicin, Diclofenac, Ketoprofen, Menthol-Based, Others); By Application (Musculoskeletal Pain, Neuropathic Pain, Cancer Pain, Post-Surgical Pain, Sports Injuries, Others); By End User (Hospitals & Surgical Centers, Retail Pharmacies, Online Pharmacies, Home Healthcare, Rehabilitation Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Non-Opioid Pain Patches Market will witness a promising CAGR of 8.2 %, valued at $3.1 billion in 2024 , and is expected to appreciate and... Read More

Published Date: OCT-2025 | No Of Pages:166 | $ 4485

Antipsychotic Drugs Market By Drug Type (Typical, Atypical); By Therapeutic Application (Schizophrenia, Bipolar Disorder, Major Depressive Disorder With Psychotic Features, Other Psychoses); By Route of Administration (Oral, Long-Acting Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Antipsychotic Drugs Market will witness a robust CAGR of 4.6 % , valued at USD 16.2 billion in 2024, expected to appreciate and reach USD... Read More

Published Date: OCT-2025 | No Of Pages:174 | $ 4485

Omega-3 Prescription Drugs Market By Product Type (EPA-Only Formulations, Combination EPA/DHA Formulations); By Application (Severe Hypertriglyceridemia, Cardiovascular Event Risk Reduction, Other Emerging Indications); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies & Specialty Distributors); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Omega-3 Prescription Drugs Market will witness a robust CAGR of 6.4% , valued at $2.1 billion in 2024, expected to appreciate and reach $3.1 billion by 20... Read More

Published Date: OCT-2025 | No Of Pages:195 | $ 4485

Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Tumor Necrosis Factor Inhibitor Drugs Market By Product Type (Monoclonal Antibodies, Fusion Proteins, Biosimilars); By Route of Administration (Subcutaneous, Intravenous); By Indication (Rheumatoid Arthritis, Ankylosing Spondylitis, Crohn’s Disease, Psoriasis, Ulcerative Colitis, Others); By End User (Hospitals & Specialty Clinics, Ambulatory Infusion Centers, Homecare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Tumor Necrosis Factor Inhibitor Drugs Market will witness a robust CAGR of 7.1% , valued at approximately USD 36.7 Read More

Published Date: OCT-2025 | No Of Pages:193 | $ 4485

Liposomal Doxorubicin Market By Product Type (Conventional Liposomal Doxorubicin, PEGylated Liposomal Doxorubicin, Non-PEGylated Liposomal Doxorubicin); By Cancer Type (Breast Cancer, Ovarian Cancer, Kaposi’s Sarcoma, Multiple Myeloma, Other Solid Tumors); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Liposomal Doxorubicin Market will witness a robust CAGR of 6.9% , valued at $1.42 billion in 2024 , expected to appreciate and reach $2.13 billion... Read More

Published Date: OCT-2025 | No Of Pages:180 | $ 4485

Pediatric Vaccines Market By Vaccine Type (Inactivated, Live Attenuated, Conjugate, Toxoid, Subunit/Recombinant, mRNA); By Disease Indication (MMR, DTaP, Polio, Pneumococcal, Hepatitis, Rotavirus, Hib, Others); By Route of Administration (Intramuscular, Subcutaneous, Oral); By Distribution Channel (Public Programs, Private Clinics, Hospitals, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction and Strategic Context

The Global Pediatric Vaccines Market will witness a robust CAGR of approximately 6.4%, valued at USD 49.3 billion in 2024, expected to appreciate and reach USD 73.9 billion by 2030, confirms Strategic Market Research.Read More

Published Date: OCT-2025 | No Of Pages:160 | $ 4485

Burn Ointment Market By Product Type (Antimicrobial Burn Ointments, Moisturizing Burn Creams, Pain-Relief Burn Gels, Regenerative and Bioactive Formulations); By Burn Severity (Minor Burns, Partial-Thickness Burns, Full-Thickness Burns); By End User (Hospitals, ASCs, Retail Pharmacies and Online, Military and Research Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Burn Ointment Market will witness a robust CAGR of 6.4% , valued at $1.45 billion in 2024 , expected to appreciate and reach $ 2.5 Read More

Published Date: OCT-2025 | No Of Pages:189 | $ 4485

Cholera Vaccines Market By Vaccine Type (Killed/Inactivated, Live Attenuated); By End User (Public Health Agencies, NGOs, Hospitals & Clinics, Military & Travelers); By Route of Administration (Oral, Parenteral); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cholera Vaccines Market will witness a robust CAGR of 8.7% , valued at $113.4 million in 2024 , and is expected to appreciate and reach $186.2 million by 2030Read More

Published Date: OCT-2025 | No Of Pages:162 | $ 4485

Enteric Empty Capsules Market By Material Type (Gelatin Capsules, Non-Gelatin Capsules [HPMC and Others]); By Release Mechanism (pH-Dependent Release, Time-Dependent Release, Enzyme-Triggered Release); By End User (Pharmaceutical Companies, Nutraceutical Companies, CMOs/CDMOs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Enteric Empty Capsules Market will witness a robust CAGR of 4.56 % , valued at USD 995 million in 2024, expected to appreciate and reach about USD... Read More

Published Date: OCT-2025 | No Of Pages:167 | $ 4485

Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market By Product Type (Non-Selective COX Inhibitors, COX-2 Selective Inhibitors, Salicylates); By Route of Administration (Oral, Topical, Parenteral); By Application (Osteoarthritis, Rheumatoid Arthritis, Acute Pain, Chronic Back Pain, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Non-Steroidal Anti-Inflammatory Drugs Market will witness a robust CAGR of 9.78 % , valued at $ 11.23 billion in 2024 , ... Read More

Published Date: OCT-2025 | No Of Pages:196 | $ 4485

Nanocapsules Market By Material Type (Polymeric Nanocapsules, Lipid-Based Nanocapsules, Hybrid Nanocapsules); By Application (Pharmaceuticals, Cosmetics & Personal Care, Food & Nutraceuticals, Agrochemicals, Others); By End User (Pharmaceutical & Biotechnology Companies, Cosmetic Manufacturers, Food & Beverage Companies, Agriculture Sector, Academic & Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Nanocapsules Market will witness a robust CAGR of 13.8% valued at $3.9 billion in 2024, expected to appreciate and reach $8.6 bil... Read More

Published Date: OCT-2025 | No Of Pages:173 | $ 4485

Antifungal Drugs Market By Drug Type (Azoles, Echinocandins, Polyenes, Allylamines, Others); By Indication (Superficial Fungal Infections, Systemic Fungal Infections); By Route of Administration (Oral, Topical, Parenteral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Antifungal Drugs Market will witness a robust CAGR of 5.7% , valued at approximately $16.3 billion in 2024 , and is expected to appreciat... Read More

Published Date: OCT-2025 | No Of Pages:162 | $ 4485

Migraine Drugs Market By Drug Type (Abortive Drugs [Triptans, CGRP Receptor Antagonists, NSAIDs, Ergot Alkaloids]; Preventive Drugs [Beta-Blockers, Antiepileptic Drugs, CGRP Monoclonal Antibodies, Antidepressants]); By Route of Administration (Oral, Injectable, Nasal Spray, Transdermal); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Migraine Drugs Market will witness a robust CAGR of 8.2 % , valued at $7.9 billion in 2024 , and is expected to appreciate significantly ... Read More

Published Date: OCT-2025 | No Of Pages:165 | $ 4485

Peptide Antibiotics Market By Product Type (Natural Peptides, Synthetic Peptides); By Application (Hospital-Acquired Infections, Skin and Soft Tissue Infections, Others); By End User (Hospitals and Clinics, Pharmaceutical Companies, Research Institutes); By Region (North America, Europe, Asia Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Peptide Antibiotics Market will witness a robust CAGR of 9.2% , valued at USD 1.85 billion in 2024, expected to appreciate and reach USD 3.19 bill... Read More

Published Date: OCT-2025 | No Of Pages:200 | $ 4485

Human Papillomavirus (HPV) Vaccine Market By Vaccine Type (Bivalent, Quadrivalent, Nonavalent); By Age Group (9–14 Years, 15–26 Years, Above 26 Years); By Distribution Channel (Government Supplies, Private Clinics & Hospitals, Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Human Papillomavirus ( HPV ) Vaccine Market will witness a robust CAGR of 6.8% , valued at $5.2 billion in 2024 , expect... Read More

Published Date: OCT-2025 | No Of Pages:188 | $ 4485

Somatostatin Analogs Market By Product Type (Short-Acting, Long-Acting); By Indication (Acromegaly, Neuroendocrine Tumors, Cushing’s Disease, Others); By Route of Administration (Intramuscular, Subcutaneous, Intravenous); By Distribution Channel (Hospitals, Specialty Clinics, Retail & Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Globa l Somatostatin Analogs Market will witness a robust CAGR of 6.4% , valued at $4.2 billion in 2024 , expe... Read More

Published Date: OCT-2025 | No Of Pages:167 | $ 4485

Intravenous Iron Drugs Market By Product Type (Ferric Carboxymaltose, Iron Sucrose, Ferumoxytol, Ferric Derisomaltose, Others); By Application (Chronic Kidney Disease, Iron Deficiency Anemia in Non-Dialysis Patients, Oncology and Chemotherapy-Induced Anemia, Gastroenterology, Women’s Health, Surgery and Perioperative Care); By End User (Hospitals, Outpatient Clinics and Infusion Centers, Dialysis Centers, Specialty Care Practices); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Intravenous Iron Drugs Market will witness a robust CAGR of 8.2% , valued at USD 2.25 billion in 2024, expected to appreciate and reach USD 3.61 b... Read More

Published Date: OCT-2025 | No Of Pages:185 | $ 4485

Keytruda (Pembrolizumab) Market By Cancer Type (NSCLC, Melanoma, Colorectal, Bladder, Head & Neck, Others); By Route of Administration (Intravenous, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Keytruda (Pembrolizumab) Market will witness a strong CAGR of 12.4% , valued at $26.3 billion in 2024 ,... Read More

Published Date: OCT-2025 | No Of Pages:200 | $ 4485

Fondaparinux Market By Dosage Strength (2.5 mg/0.5 ml, 5 mg/0.4 ml, 7.5 mg/0.6 ml, 10 mg/0.8 ml); By Indication (DVT, PE, ACS, HIT, Orthopedic Surgery); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Fondaparinux Market will witness a moderate yet stable CAGR of 7.3% , valued at USD 643.2 million in 2024 , and is expected to grow stead... Read More

Published Date: OCT-2025 | No Of Pages:166 | $ 4485

Measles, Mumps, and Rubella Vaccine Market By Product Type (Monovalent, MMR Combination, MMRV); By Route of Administration (Subcutaneous); By Distribution Channel (Public Sector, Private Sector); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Measles, Mumps, And Rubella (MMR) Vaccine Market will witness a steady CAGR of 5.8% , valued at $3.1 billion in 2024 , and is projected t... Read More

Published Date: OCT-2025 | No Of Pages:190 | $ 4485

Ophthalmic Drugs Market By Drug Class (Anti-Glaucoma Drugs, Anti-Inflammatory Drugs, Anti-Infective Drugs, Anti-Allergy Drugs, Retinal Disorder Therapies); By Route of Administration (Topical, Injectable, Oral, Ocular Inserts); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Ophthalmic Drugs Market will witness a robust CAGR of 6.9% , valued at $35.65 billion in 2024 , expected to appreciate and reach ... Read More

Published Date: OCT-2025 | No Of Pages:197 | $ 4485

Small Molecule API Market By Type (Innovative APIs, Generic APIs); By Manufacturing Method (In-house, Outsourced); By Therapeutic Application (Oncology, Cardiovascular, CNS, Infectious Diseases, Respiratory, Diabetes, Others); By End User (Pharmaceutical Companies, Biopharmaceutical Firms, CDMOs, Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Small Molecule API Market will witness a robust CAGR of 6.9%, valued at $203.4 billion in 2024 , and is expected to appreciate and reach ... Read More

Published Date: OCT-2025 | No Of Pages:163 | $ 4485

Gabapentin Market By Product Type (Generic, Branded); By Route of Administration (Oral Capsules/Tablets, Oral Solution, Others); By Indication (Epilepsy, Neuropathic Pain, Fibromyalgia, Off-Label Uses); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Gabapentin Market will witness a robust CAGR of 6.4% , valued at $2.87 billion in 2024 , and is expected to appreciate and reach ... Read More

Published Date: OCT-2025 | No Of Pages:182 | $ 4485

Herceptin Biosimilars Market By Product Type (Single-Agent, Combination-Ready, Lyophilized, Liquid); By Indication (HER2+ Breast Cancer, HER2+ Gastric Cancer); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Herceptin Biosimilars Market will witness a robust CAGR of 16.2%, valued at $1.84 billion in 2024 ... Read More

Published Date: OCT-2025 | No Of Pages:175 | $ 4485

Peptide Drug Conjugates Market By Product Type (Cytotoxic, Radiolabeled, Peptide-Oligonucleotide, Multivalent); By Application (Oncology, Autoimmune, Metabolic, Infectious, Neurological); By Route of Administration (IV, SC, IM, Oral); By End User (Hospitals, Clinics, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Peptide Drug Conjugates Market will witness a robust CAGR of 24.2% , valued at $1.73 billion in 2024 , expected to appreciate and reach $6.42 bill... Read More

Published Date: OCT-2025 | No Of Pages:195 | $ 4485

Inhalation Anesthesia Market By Product Type (Sevoflurane, Isoflurane, Desflurane, Nitrous Oxide); By Application (Maintenance Anesthesia, Induction Anesthesia, Sedation); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context


The Global Inhalation Anesthesia Market will witness a robust CAGR of 6.8%, valued at $2.4 billion in 2024, expected to appreciate and reach $3.99 billion by 2030, confirms Strategic Market Research.... Read More

Published Date: OCT-2025 | No Of Pages:196 | $ 4485

Aminoglycosides Market By Drug Type (Gentamicin, Amikacin, Tobramycin, Neomycin, Streptomycin, Others); By Route of Administration (Injectable, Topical, Oral); By Application (Human Health, Veterinary Health); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Aminoglycosides Market will witness a robust CAGR of 5.8% , valued at $1.24 billion in 2024 , and is expected to appreciate and reach $1.74 billion by 2030Read More

Published Date: OCT-2025 | No Of Pages:156 | $ 4485

Dopamine Agonist Market By Product Type (Ergot-Derived, Non-Ergot); By Route of Administration (Oral, Transdermal, Injectable); By Indication (Parkinson’s Disease, Restless Leg Syndrome, Hyperprolactinemia, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Dopamine Agonist Market will witness a robust CAGR of 6.5 % , valued at $3.4 billion in 2024 , expected to appreciate and reach $... Read More

Published Date: OCT-2025 | No Of Pages:156 | $ 4485

Tetanus Toxoid Vaccine Market By Product Type (Monovalent, Combination Vaccines); By Age Group (Pediatric, Adolescent & Adult); By Distribution Channel (Public Health Programs, Private Healthcare Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Tetanus Toxoid Vaccine Market will witness a robust CAGR of 5.5% , valued at approximately USD 2.4 billion in 2024 , and is expected to a... Read More

Published Date: OCT-2025 | No Of Pages:195 | $ 4485

Dermatological Drugs Market By Drug Class (Corticosteroids, Retinoids, Anti-infectives, Calcineurin Inhibitors, Biologics, Others); By Indication (Acne, Psoriasis, Atopic Dermatitis, Rosacea, Skin Infections, Skin Cancer, Others); By Route of Administration (Topical, Oral, Parenteral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Dermatological Drugs Market will witness a robust CAGR of 8.1%, valued at $27.6 billion in 2024, expected to appreciate and reach $46.3 billion ... Read More

Published Date: OCT-2025 | No Of Pages:159 | $ 4485

Urothelial Cancer Drugs Market By Drug Class (Immunotherapy Drugs, Chemotherapy Drugs, Targeted Therapies, Antibody-Drug Conjugates); By Route of Administration (Intravenous, Oral); By End User (Hospitals & Cancer Institutes, Specialty Clinics, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Urothelial Cancer Drugs Market will witness a robust CAGR of 10.2% , valued at $4.8 billion in 2024, expected to appreciate and reach $8.7 billion... Read More

Published Date: OCT-2025 | No Of Pages:192 | $ 4485

Senolytics and Anti-Aging Pharmaceuticals Market By Drug Class (Small Molecule Senolytics, Biologics, Peptides, Natural Compounds); By Mechanism of Action (Apoptotic Pathway Modulators, SASP Suppressors, DNA Repair Enhancers); By Application (Neurodegenerative Diseases, Osteoarthritis, Pulmonary Fibrosis, Cardiovascular, Dermatological); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Senolytics And Anti-Aging Pharmaceuticals Market will witness a robust CAGR of 17.2% , valued at $2.5 billion in 2024 , ... Read More

Published Date: OCT-2025 | No Of Pages:171 | $ 4485

Anticoagulants Market By Drug Type (Vitamin K Antagonists, Direct Oral Anticoagulants, Low Molecular Weight Heparin, Unfractionated Heparin, Other Parenteral Anticoagulants); By Route of Administration (Oral, Injectable); By Application (Atrial Fibrillation, Deep Vein Thrombosis, Pulmonary Embolism, Ischemic Stroke, Surgical Thromboprophylaxis); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Anticoagulants Market will witness a robust CAGR of 5.6 % , valued at $41.3 billion in 2024 , expected to appreciate and reach $<... Read More

Published Date: OCT-2025 | No Of Pages:182 | $ 4485

Intravenous Immunoglobulin Market By Product Type (Lyophilized, Liquid); By Therapeutic Indication (Primary Immunodeficiency Diseases, Chronic Inflammatory Demyelinating Polyneuropathy, Immune Thrombocytopenic Purpura, Guillain–Barré Syndrome, Others); By End User (Hospitals, Specialty Clinics & Infusion Centers, Home Care); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Intravenous Immunoglobulin ( IVIG ) Market will witness a robust CAGR of 7.8% , valued at approximately $15.6 billion in... Read More

Published Date: OCT-2025 | No Of Pages:191 | $ 4485

Osteoporosis Drugs Market By Drug Class (Bisphosphonates, SERMs, Parathyroid Hormone Analogs, RANK Ligand Inhibitors, Calcitonin & Others); By Route of Administration (Oral, Injectable); By End User (Hospitals & Specialty Clinics, Retail Pharmacies, Online Pharmacies, Long-Term Care Facilities); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Osteoporosis Drugs Market will witness a robust CAGR of 5.8% , valued at $7.69 billion in 2024 , expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:191 | $ 4485

Nasal Spray Market By Product Type (Decongestant Nasal Sprays, Steroid Nasal Sprays, Saline Nasal Sprays, Antihistamine Nasal Sprays, Other Nasal Sprays); By Application (Allergic Rhinitis, Sinusitis, Common Cold & Congestion, Nasal Polyps, Migraine & Neurological Treatments, Vaccination); By End User (Hospitals & Clinics, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Nasal Spray Market will witness a robust CAGR of 6.8% , valued at approximately USD 14.3 billion in 2024, and is expected to appreciate a... Read More

Published Date: OCT-2025 | No Of Pages:158 | $ 4485

GLP-1 Receptor Agonists Market By Product Type (Injectable GLP-1 Receptor Agonists, Oral GLP-1 Receptor Agonists); By Indication (Type 2 Diabetes Mellitus, Obesity and Weight Management); By Route of Administration (Subcutaneous, Oral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global GLP -1 Receptor Agonists Market will witness a robust CAGR of 12.3% , valued at $18.4 billion in 2024 , expected to appreciate and reach ... Read More

Published Date: OCT-2025 | No Of Pages:164 | $ 4485

Pharmaceutical Lipids Market By Product Type (Triglycerides, Phospholipids, Sphingolipids, Sterols); By Application (Drug Delivery Systems, Vaccines, Nutraceuticals); By Form (Liquid, Solid); By End User (Pharmaceutical Companies, Biotechnology Firms, CMOs, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pharmaceutical Lipids Market will witness a robust CAGR of 10.23 % , valued at $6.3 billion in 2024 , expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:196 | $ 4485

Respiratory Disease Vaccine Market By Vaccine Type (Live Attenuated, Inactivated, Subunit/Recombinant/Polysaccharide/Conjugate, mRNA); By Disease Indication (Influenza, COVID-19, RSV, Pneumococcal, Others); By Route of Administration (Injectable, Intranasal); By Age Group (Pediatric, Adult, Geriatric); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Respiratory Disease Vaccine Market will witness a robust CAGR of 8.2% , valued at $24.7 billion in 2024 , expected to ap... Read More

Published Date: OCT-2025 | No Of Pages:153 | $ 4485

Schizophrenia Drugs Market By Drug Class (Second-Generation Antipsychotics, First-Generation Antipsychotics, Adjunctive Therapies); By Route of Administration (Oral, Long-Acting Injectables, Others); By Treatment Phase (Acute, Maintenance, Treatment-Resistant); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Schizophrenia Drugs Market will witness a robust CAGR of 5.9% , valued at $8.4 billion in 2024 , and is expected to appreciate and reach $ 10.82Read More

Published Date: OCT-2025 | No Of Pages:170 | $ 4485

Atopic Dermatitis Drugs Market By Drug Type (Biologics, Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Antihistamines, Others); By Route of Administration (Topical, Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Atopic Dermatitis Drugs Market will witness a robust CAGR of 10.2% , valued at USD 6.8 billion in 2024 , and is expected to appreciate and reach USD 13.5 billion b... Read More

Published Date: OCT-2025 | No Of Pages:190 | $ 4485

Prostaglandin Analogs Market By Product Type (Latanoprost, Bimatoprost, Travoprost, Tafluprost, Misoprostol, Dinoprostone, Carboprost); By Application (Glaucoma and Ocular Hypertension, Reproductive Health, Gastric Ulcer Prevention, Erectile Dysfunction, Pulmonary Arterial Hypertension); By Route of Administration (Topical, Oral, Vaginal, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, NGO/Government Channels); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Prostaglandin Analogs Market will grow at a steady CAGR Of 6.1%, valued at USD 3.2 Billion In 2024 , and is projected to reach nearly USD 4.6 Billion By 2030,Read More

Published Date: OCT-2025 | No Of Pages:184 | $ 4485

Long-Acting Beta-Agonists Market By Drug Type (Formoterol, Salmeterol, Indacaterol, Olodaterol, Others); By Combination Class (LABA Monotherapy, LABA + ICS, LABA + LAMA, LABA + ICS + LAMA); By Indication (Asthma, COPD, Others); By Route of Administration (Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Long-Acting Beta-Agonists (LABA) Market is forecast to grow at a CAGR Of 6.1% , reaching USD 5.6 Billion By 2030 , up from USD 3.9 Billion In 2024 , accor... Read More

Published Date: OCT-2025 | No Of Pages:200 | $ 4485

Artificial Saliva Market By Product Type (Sprays, Gels, Solutions & Rinses, Tablets & Lozenges); By Application (Oncology Supportive Care, Post-Surgical Recovery, Sjögren’s Syndrome, Geriatric Xerostomia, Dental Use); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Platforms, Dental Clinics); By End User (Hospitals & Clinics, Long-Term Care Facilities, Dental Practices, Home Care Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Artificial Saliva Market is expected to register a moderate but steady CAGR of 6.1% , growing from an estimated USD 1.28 billion in 2024 to around USD 1.82 billion... Read More

Published Date: OCT-2025 | No Of Pages:176 | $ 4485

Testosterone Replacement Therapy Market By Product Type (Injectables, Topical Gels & Creams, Transdermal Patches, Oral Capsules, Nasal Gels, Subcutaneous Implants); By Application (Male Hypogonadism, Gender-Affirming Therapy, Delayed Puberty, Post-Chemotherapy Recovery, Off-Label Use); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By End User (Hospitals, Specialty Clinics, Home Care, Telehealth Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Testosterone Replacement Therapy ( TRT ) Market is set to expand significantly, witnessing a robust CAGR of 6.7 % . The market is valued ... Read More

Published Date: OCT-2025 | No Of Pages:178 | $ 4485

Pharmaceutical Excipients Market By Product Type (Polymers, Alcohols, Sugars, Minerals, Gelatin and Others); By Functionality (Binders, Fillers & Diluents, Disintegrants, Preservatives, Coating Agents, Flavoring Agents, Lubricants and Glidants); By Formulation Type (Oral, Topical, Parenteral, Others); By End Use (Pharmaceutical Companies, Biopharmaceutical Companies, CMOs/CDMOs, Academic Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Pharmaceutical Excipients Market will witness a robust CAGR of 7.2% , valued at $10.4 billion in 2024 , and is expected to appreciate and reach $1... Read More

Published Date: OCT-2025 | No Of Pages:187 | $ 4485

Blood Coagulants Market By Product Type (Plasma-Derived Coagulants, Recombinant Coagulation Factors, Fibrin Sealants, Topical Hemostats, Others); By Application (Hemophilia A and B, Surgical Procedures, Liver Disease–Associated Bleeding, Anticoagulant Reversal, Trauma-Induced Coagulopathy); By End User (Hospitals & Surgical Centers, Hemophilia Treatment Centers, Retail Pharmacies, Emergency Care Clinics, Military and Trauma Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Blood Coagulants Market will witness a robust CAGR of 7.6% , valued at $14.2 billion in 2024 , expected to appreciate and reach $... Read More

Published Date: OCT-2025 | No Of Pages:200 | $ 4485

Topical Drug Delivery Market By Product Type (Semi-solid Formulations, Liquid Formulations, Solid Formulations, Transdermal Patches); By Route of Administration (Dermal, Ophthalmic, Rectal, Vaginal, Nasal); By Application (Pain Management, Dermatology, Hormone Replacement Therapy, Infectious Disease Treatment, Ophthalmology, Cosmetic Applications); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Topical Drug Delivery Market will witness a robust CAGR of 11.74 % , valued at USD 99.3 billion in 2024... Read More

Published Date: OCT-2025 | No Of Pages:198 | $ 4485

Epilepsy Drugs Market By Drug Type (First-Generation AEDs, Second- & Third-Generation AEDs); By Mechanism of Action (Sodium Channel Blockers, GABA Modulators, SV2A Modulators, AMPA Antagonists); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Epilepsy Drugs Market will witness a robust CAGR of 6.4 % , valued at $5.3 billion in 2024 , and is expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:200 | $ 4485

Transdermal Patches Market By Product Type (Drug-in-Adhesive, Matrix, Reservoir, Microneedle, Vapor); By Application (Pain Management, Hormone Replacement, Smoking Cessation, CNS Disorders, Cardiovascular, Oncology, Motion Sickness); By End User (Hospitals, Homecare, Long-term Care, Military, Pharmacies); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Transdermal Patches Market will witness a robust CAGR of 6.8% , valued at $8.7 billion in 2024 , expected to appreciate and reach $13.0 billion by 2030 , ... Read More

Published Date: OCT-2025 | No Of Pages:172 | $ 4485

Organ Transplant Immunosuppressant Drugs Market By Drug Type (Calcineurin Inhibitors, Antiproliferative Agents, mTOR Inhibitors, Corticosteroids, Monoclonal Antibodies & Biologics); By Transplant Type (Kidney, Liver, Heart, Lung, Pancreas & Multi-Organ); By Route of Administration (Oral, Intravenous, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Organ Transplant Immunosuppressant Drugs Market will witness a robust CAGR of 6.3% , valued at $5.9 billion in 2024 , expected to appreciate and reach $9.0 billion... Read More

Published Date: OCT-2025 | No Of Pages:180 | $ 4485

Oral Solid Dosage Contract Manufacturing Market By Product Type (Tablets, Capsules, Others); By End-User (Pharmaceutical Companies, Nutraceutical Manufacturers, CMOs); By Region (North America, Europe, Asia-Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Oral Solid Dosage (OSD) Contract Manufacturing Market will witness a robust CAGR of 7.5% , valued at $25 billion in 2024 , and is expected to ap... Read More

Published Date: OCT-2025 | No Of Pages:193 | $ 4485

Kidney Transplant Medicine Market By Drug Class (Calcineurin Inhibitors, mTOR Inhibitors, Antimetabolites, Monoclonal Antibodies, Steroids & Adjuvant Therapies); By Route of Administration (Oral, Intravenous); By End User (Hospitals & Transplant Centers, Specialty Clinics, Home Care & Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Kidney Transplant Medicine Market will witness a robust CAGR of 5.8% , valued at $2.91 billion in 2024 , expected to appreciate and reach $4.09 bi... Read More

Published Date: OCT-2025 | No Of Pages:194 | $ 4485

Unit Dose Packaging Market By Material Type (Plastic, Aluminum Foil, Paper & Paperboard, Biodegradable Films); By Packaging Format (Blister Packs, Vials & Ampoules, Pre-filled Syringes, Pouches & Sachets, Stick Packs, Tubes); By End Use (Pharmaceuticals, Nutraceuticals, Food & Beverage, Personal Care, Veterinary); By Technology (Thermoforming, Cold Forming, Injection Molding, Form-Fill-Seal, RF Sealing); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Unit Dose Packaging Market will witness a steady CAGR of 7.1% , valued at $32.6 billion in 2024 , and is expected to appreciate and reach $52.4 bi... Read More

Published Date: OCT-2025 | No Of Pages:181 | $ 4485

Oral Solid Dosage CDMO Market By Product Type (Tablets, Capsules, Powders & Granules, Lozenges); By Phase (Preclinical & Clinical Manufacturing, Commercial Manufacturing); By End User (Pharmaceutical Companies, Biotechnology Firms, Nutraceutical Companies); By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa); Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Oral Solid Dosage CDMO (Contract Development And Manufacturing Organization) Market wi... Read More

Published Date: OCT-2025 | No Of Pages:172 | $ 4485

Topical Drugs Contract Manufacturing Market By Product Type (Creams, Ointments, Gels, Transdermal Patches, Sprays, Others); By Therapeutic Area (Dermatology, Pain Management, Infectious Diseases, Oncology, Others); By End User (Large Pharma, Generic Manufacturers, Specialty Pharma, OTC Product Marketers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Topical Drugs Contract Manufacturing Market will witness a robust CAGR of 6.8% , valued at $34.2 billion in 2024 , expected to appreciate and reach $50.9 billion b... Read More

Published Date: OCT-2025 | No Of Pages:183 | $ 4485

Proton Pump Inhibitors (PPI) Market By Product Type (Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, Rabeprazole, Dexlansoprazole); By Route of Administration (Oral, Intravenous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction and Strategic Context

The Global Proton Pump Inhibitors (PPI) Market will witness a steady CAGR of 6.3%, valued at $3.89 billion in 2024, and is expected to appreciate and reach <... Read More

Published Date: OCT-2025 | No Of Pages:151 | $ 4485

Ophthalmic Suspension Market By Drug Class (Antibiotics, Corticosteroids, NSAIDs, Combination Drugs, Others); By Application (Post-Operative Eye Care, Conjunctivitis, Uveitis, Dry Eye Syndrome, Glaucoma, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Ophthalmic Suspension Market will witness a robust CAGR of 6.9% , valued at USD 3.2 billion in 2024 , expected to appreciate and reach USD 4.8 billion by 2030Read More

Published Date: OCT-2025 | No Of Pages:152 | $ 4485

Gastroretentive Drug Delivery Systems Outsourcing Market By Delivery System Type (Floating Drug Delivery Systems, Mucoadhesive Systems, High-Density Systems, Expandable Systems, Superporous Hydrogel Systems); By Drug Type (Branded Drugs, Generic Drugs); By Outsourcing Type (Formulation Development, Process Optimization and Scale-Up, Analytical Testing and Regulatory Filing, Manufacturing and Packaging); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Gastroretentive Drug Delivery Systems Outsourcing Market is poised to grow at a robust CAGR of 9.7% , valued at USD 1.43 billion in 2024 ... Read More

Published Date: OCT-2025 | No Of Pages:189 | $ 4485

Dipeptidyl Peptidase 1 (DPP1) / Cathepsin C Inhibitor Market By Molecule Type (Small-Molecule Inhibitors, Biologic Inhibitors); By Indication (Generalized Pustular Psoriasis, Non-Cystic Fibrosis Bronchiectasis, Severe Chronic Periodontitis, Other Rare Neutrophil-Mediated Disorders); By Route of Administration (Oral, Subcutaneous, Injectable); By End User (Specialty Hospitals, Dermatology & Pulmonology Clinics, Research Centers, Hospital Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Dipeptidyl Peptidase 1 (DPP1) / Cathepsin C Inhibitor Market will witness a robust CAGR of 10.2%, valued at USD 1.2 billion in 2024, expected to reach USD 2.1 b... Read More

Published Date: OCT-2025 | No Of Pages:158 | $ 4485

CGRP Inhibitors Market By Product Type (Receptor Antagonists, Ligand Blockers); By Route of Administration (Oral, Injectable, Intranasal); By End User (Hospitals & Neurology Clinics, Retail Pharmacies, Online & Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CGRP Inhibitors Market will witness a robust CAGR of 13.6% , valued at $2.4 billion in 2024 , expected to appreciate and reach $5... Read More

Published Date: OCT-2025 | No Of Pages:182 | $ 4485

Acetaminophen Market By Product Type (Single-ingredient Tablets & Caplets, Pediatric Oral Liquids & Suspensions, Effervescent & Orodispersible Tablets, Rectal Suppositories, Intravenous Formulations); By Route of Administration (Oral, Rectal, Intravenous); By Distribution Channel (Retail Pharmacies & Drug Stores, Supermarkets & Mass Merchandisers, Online, Hospital Pharmacies); By Application (Pain Management, Fever Reduction, Post-operative/Inpatient Use, Combination Cold & Flu Treatments); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

1. Introduction and Strategic Context

The Global Acetaminophen Market will witness a robust CAGR of 4.8%, valued at $10.6 billion in 2024 , expected to appreciate and reach $14.1 billion by 20... Read More

Published Date: OCT-2025 | No Of Pages:184 | $ 4485

Selective Serotonin Reuptake Inhibitors (SSRIs) Market By Drug Type (Fluoxetine, Sertraline, Paroxetine, Escitalopram, Citalopram, Fluvoxamine); By Application (Depression, Anxiety Disorders, OCD, PTSD, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Selective Serotonin Reuptake Inhibitors Market is expected to grow steadily, clocking a CAGR of 6.3% between 2024 and 2030. Estimated at USD 19... Read More

Published Date: OCT-2025 | No Of Pages:165 | $ 4485

Retinal Drugs Market By Drug Class (Anti-VEGF Agents, Corticosteroids, Gene Therapies, Immunomodulators & Others); By Indication (Age-Related Macular Degeneration, Diabetic Retinopathy & DME, Retinal Vein Occlusion, Inherited Retinal Disorders); By Route of Administration (Intravitreal Injections, Sustained Release Implants, Gene Therapy, Topical & Systemic); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Retinal Drugs Market is projected to grow at a steady pace, with an estimated CAGR of 6.4% between 2024 and 2030. Market value is expected to reach USD 22.1 bil... Read More

Published Date: OCT-2025 | No Of Pages:197 | $ 4485

Travel Vaccines Market By Vaccine Type (Hepatitis A & B, Typhoid, Yellow Fever, Rabies, Cholera, Japanese Encephalitis, Meningococcal, Others); By Traveler Type (Leisure Travelers, Business Travelers, VFRs, Aid Workers & Expatriates); By Distribution Channel (Hospitals & Travel Clinics, Retail Pharmacies, Government Centers, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Travel Vaccines Market will witness a steady CAGR of 6.8%, valued at 4.7 billion dollars in 2024 and projected to reach nearly 7 billion dollars by 2030Read More

Published Date: SEP-2025 | No Of Pages:190 | $ 4485

Marine Pharmaceuticals Market By Product Type (Small Molecules, Enzymes, Toxins); By Application (Oncology, Infectious Diseases, Neurology, Inflammatory Disorders); By End User (Pharmaceutical & Biotech Companies, Academic Institutes, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Marine Pharmaceuticals Market is projected to grow at a CAGR of 9.1% between 2024 and 2030, climbing from USD 6.8 billion in 2024 to approximately USD 11.5 bill... Read More

Published Date: SEP-2025 | No Of Pages:160 | $ 4485

Liposomal Products Market by Product Type (Liposomal Drug Delivery Systems, Liposomal Cosmetics, Liposomal Nutraceuticals); By Application (Oncology, Infectious Diseases, Pain Management, Cosmetics, Gene Therapy); By End User (Pharmaceutical Companies, Healthcare Providers, Cosmetic Manufacturers, Research Institutions, Consumers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

1. Introduction and Strategic Context

The Global Liposomal Products Market is poised for substantial growth, driven by innovations in drug delivery technologies and increasing demand for more targeted therapies. Valued at approximatel... Read More

Published Date: SEP-2025 | No Of Pages:189 | $ 4485

Leuprolide Acetate Market by Product Type (Depot Injection, Daily Injection); By Application (Oncology, Gynecology, Fertility); By End-User (Hospitals, Specialty Clinics, Diagnostic Centers, ASCs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Leuprolide Acetate Market is expected to grow at a steady rate over the forecast period of 2024-2030. Leuprolide acetate, a synthetic analog of the naturally occurring gonadotropin-rele... Read More

Published Date: SEP-2025 | No Of Pages:167 | $ 4485

Natamycin Market by Application (Food & Beverages, Pharmaceuticals, Agriculture); By End User (Food Manufacturers, Pharmaceutical Companies, Agricultural Sector); By Region, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Natamycin Market is anticipated to see steady growth from 2024 to 2030 , driven by its wide application across the food and beverage industry, as well ... Read More

Published Date: SEP-2025 | No Of Pages:174 | $ 4485

Bacteriostatic Water for Injection Market By Packaging Type (Vials, Ampoules); By Application (Drug Reconstitution, Intravenous Therapy Dilution, Hormone & Peptide Injections, Cosmetic & Aesthetic Procedures, Veterinary Use); By End User (Hospitals, Specialty Clinics, Compounding Pharmacies, Home Healthcare, Veterinary Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

1. Introduction and Strategic Context

The Global Bacteriostatic Water For Injection Market is projected to expand at a CAGR of 5.9%, growing from an estimated USD 905 million in 2024 to around USD 1.35 billion by 2030, according to Strategic Market Re... Read More

Published Date: SEP-2025 | No Of Pages:166 | $ 4485